Laura J. Tafe

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis

Yelena Y. Janjigian, Dominique Werner, Claudia Pauligk et al. · Annals of Oncology · 2012 · 367 citations

Medicine, Oncology, Pathology +17

Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of <i>EGFR</i> / <i>KRA</i> S and Presence of <i>PIK3CA</i> / <i>AKT1</i> Mutations

Natasha Rekhtman, Paul K. Paik, Maria E. Arcila et al. · Clinical Cancer Research · 2012 · 365 citations · Full text

Medicine, Oncology, Pathology +17

Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms

Laura J. Tafe, Karuna Garg, Ivy Chew et al. · Modern Pathology · 2010 · 259 citations

Medicine, Oncology, Pathology +14

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy et al. · Journal for ImmunoTherapy of Cancer · 2018 · 151 citations · Full text

Life Sciences, Dermatology, Oncology +17

The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma

Anna Biernacka, Peter Tsongalis, Jason D. Peterson et al. · Cancer Genetics · 2016 · 121 citations · Full text

Medicine, Genetics, Oncology +17